数据宝统计，截至14:33，嘉事堂成交额10.17亿元，创2022年12月6日以来新高。最新股价下跌7.53%， 换手率19.13%。上一交易日该股全天成交额为4.03亿元。（数据宝） （文章来源：证券时报网） ...

（编辑 任世碧） 证券日报网讯 1月7日，嘉事堂发布公告称，公司股票交易价格连续三个交易日内（2026年1月5日、 2026年1月6日、2026年1月7日）日收盘价格涨幅累计偏离29.61%，属于股票交易异常波动的情况。经 核实，公司前期披露的信息不存在需要更正、补充之处；公司未发现近期公共传媒报道了可能或已经对 公司股票交易价格产生较大影响的未公开信息；近期公司经营情况及内外部经营环境未发生重大变化。 ...

南财智讯1月7日电，嘉事堂公告，公司股票交易价格连续三个交易日内（2026年1月5日、2026年1月6 日、2026年1月7日）日收盘价格涨幅累计偏离29.61%，根据深圳证券交易所交易规则的有关规定，属 于股票交易异常波动的情况。经核查，公司前期披露的信息不存在需要更正、补充之处；近期公共传媒 未报道可能或已经对公司股票交易价格产生较大影响的未公开信息；近期公司经营情况及内外部经营环 境未发生重大变化；公司、控股股东和实际控制人不存在应披露而未披露的重大事项或处于筹划阶段的 重大事项；股票异常波动期间，控股股东和实际控制人不存在买卖本公司股票的行为。公司董事会确 认，目前没有任何应予以披露而未披露的事项，也未获悉对本公司股票及其衍生品种交易价格产生较大 影响的信息。 ...

嘉事堂公告称，公司股票在2026年1月5 - 7日连续三个交易日内，日收盘价格涨幅累计偏离29.61%，属 股票交易异常波动。公司核查后表示，前期披露信息无需更正补充，未发现公共传媒报道可能影响股价 的未公开信息，近期经营及内外部环境无重大变化，公司、控股股东和实控人无应披露未披露重大事 项，异常波动期间控股股东和实控人无买卖公司股票行为。公司提醒投资者以指定媒体信息为准，理性 投资。 ...

证券代码：002462 证券简称：嘉事堂 公告编号： 2026-01 嘉事堂药业股份有限公司 股票交易异常波动公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证信息披露的内容真实、准确、 完整，没有虚假记载、误导性陈述或重大遗漏。 一、股票交易异常波动的情况介绍 嘉事堂药业股份有限公司（以下简称"公司"）股票交易价格连续三个交易 日内（2026 年 1 月 5 日、2026 年 1 月 6 日、2026 年 1 月 7 日）日收盘价格涨 幅累计偏离 29.61%，根据《深圳证券交易所交易规则》的有关规定，属于股票 交易异常波动的情况。 二、公司关注并核实相关情况 针对公司股票交易异常波动，根据相关规定的要求，公司对有关事项进行 了核查，现对相关情况说明如下： 1、公司前期披露的信息不存在需要更正、补充之处； 2、公司未发现近期公共传媒报道了可能或已经对公司股票交易价格产生较 大影响的未公开信息。 3、近期公司经营情况及内外部经营环境未发生重大变化； 4、公司、控股股东和实际控制人目前不存在关于本公司的应披露而未披露 的重大事项或处 ...

Group 1 - The core viewpoint of the article highlights the fluctuation of the Guozheng Free Cash Flow Index, which experienced a decline of approximately 0.4% in early trading on January 7, with component stocks showing mixed performance [1] - Notable stocks such as Jiashitang, China Chemical, Anfu Technology, Mona Lisa, and Nanshan Aluminum saw gains, indicating selective strength within the market [1] - The largest free cash flow ETF (159201) has seen a continuous net inflow of funds totaling 641 million yuan over the past four days, reaching a new high of 9.213 billion yuan since its inception [1] Group 2 - Dongwu Securities' research report suggests that the A-share market is experiencing an improvement in liquidity, driven by cross-border capital inflows and the upcoming insurance "New Year" funds entering the market [1] - The report indicates that the recovery of the RMB exchange rate may boost market sentiment and potentially lead to incremental capital through corporate and household sectors [1] - Free cash flow is emphasized as the foundation for dividend distribution, focusing on a company's internal growth capabilities, while dividend strategies emphasize the results of dividend distribution [1] Group 3 - The free cash flow strategy is noted to complement growth stock investments, serving as a foundational tool for balancing such investments [1] - The free cash flow ETF (159201) and its linked funds (A: 023917; C: 023918) closely track the Guozheng Free Cash Flow Index, with management fees at 0.15% and custody fees at 0.05%, representing the lowest rates in the market [1]

| 日期 | 当日涨跌幅（%） | 换手率（%） | 主力资金净流入（万元） | | --- | --- | --- | --- | | 2026.01.06 | 10.00 | 4.10 | 10140.83 | | 2026.01.05 | 10.03 | 7.71 | 9438.20 | | 2025.12.31 | -2.05 | 1.84 | -1444.06 | | 2025.12.30 | -0.14 | 1.36 | -5.53 | | 2025.12.29 | -2.85 | 2.61 | -1358.05 | | 2025.12.26 | -0.26 | 2.28 | -218.48 | | 2025.12.25 | -0.53 | 2.03 | -681.93 | | 2025.12.24 | 0.33 | 2.32 | -887.15 | | 2025.12.23 | -2.38 | 3.62 | -730.01 | | 2025.12.22 | -2.51 | 3.63 | -917.58 | （文章来源：证券时报网） 近日该股表现 嘉事堂盘中涨停，已连收3个涨停板，截至9:25，该 ...

Market Performance - The pharmaceutical commercial sector increased by 0.97% compared to the previous trading day, with Luyuan Pharmaceutical leading the gains [1] - The Shanghai Composite Index closed at 4083.67, up by 1.5%, while the Shenzhen Component Index closed at 14022.55, up by 1.4% [1] Individual Stock Performance - Key stocks in the pharmaceutical commercial sector showed significant gains, with Yinghe Pharmaceutical rising by 10.02% to a closing price of 22.72, and Jiashitang also increasing by 10.00% to 17.38 [1] - Other notable performers included Saili Medical and Renmin Tongtai, both showing increases of 10.00% and 2.64% respectively [1] Trading Volume and Value - Yinghe Pharmaceutical had a trading volume of 636,200 shares, resulting in a transaction value of approximately 1.396 billion yuan [1] - Jiashitang and Saili Medical also reported substantial trading volumes of 119,600 and 74,200 shares, with transaction values of around 208 million yuan and 185 million yuan respectively [1] Capital Flow Analysis - The pharmaceutical commercial sector experienced a net outflow of 188 million yuan from institutional investors and 252 million yuan from speculative funds, while retail investors saw a net inflow of 439 million yuan [2] - The capital flow data indicates varying investor sentiment, with retail investors showing a positive trend in the sector [2] Stock-Specific Capital Flow - Luyuan Pharmaceutical had a net inflow from retail investors of approximately 1.02 billion yuan, despite a net outflow from institutional and speculative investors [3] - Jiashitang and Saili Medical also experienced mixed capital flows, with Jiashitang seeing a net inflow of 84.96 million yuan from institutional investors [3]

Market Performance - The pharmaceutical commercial sector increased by 1.77% compared to the previous trading day, with Jia Shitang leading the gains [1] - The Shanghai Composite Index closed at 4023.42, up 1.38%, while the Shenzhen Component Index closed at 13828.63, up 2.24% [1] Individual Stock Performance - Jia Shitang (002462) closed at 15.80, up 10.03% with a trading volume of 224,800 shares [1] - Saily Medical (603716) closed at 22.61, up 10.02% with a trading volume of 133,500 shares [1] - Baiyang Pharmaceutical (301015) closed at 25.23, up 6.91% with a trading volume of 83,200 shares [1] - Other notable performers include Dajia Weikang (301126) up 6.51%, and Run Da Medical (603108) up 5.82% [1] Capital Flow Analysis - The pharmaceutical commercial sector saw a net inflow of 231 million yuan from institutional investors, while retail investors contributed a net inflow of 71.88 million yuan [2] - However, there was a net outflow of 303 million yuan from speculative funds [2] Detailed Capital Flow for Key Stocks - Saily Medical (603716) had a net inflow of 1.59 billion yuan from institutional investors, but a net outflow of 71.84 million yuan from speculative funds [3] - Jia Shitang (002462) experienced a net inflow of 86.98 million yuan from institutional investors, with a net outflow of 45.96 million yuan from speculative funds [3] - Hua Ren Health (301408) had a net inflow of 45.75 million yuan from institutional investors, but a significant net outflow of 65.32 million yuan from retail investors [3]

Market Overview - The Shanghai Composite Index closed at 4023.42 points, above the six-month moving average, with an increase of 1.38% [1] - The total trading volume of A-shares reached 30,483.30 billion yuan [1] Stocks Above Six-Month Moving Average - A total of 313 A-shares have surpassed the six-month moving average today [1] - Notable stocks with significant deviation rates include: - BeiYikang (证券代: 920199) with a deviation rate of 19.09% and a price increase of 29.98% [1] - *ST Huike (证券代: 300561) with a deviation rate of 18.68% and a price increase of 19.99% [1] - Weisi Medical (证券代: 688580) with a deviation rate of 18.24% and a price increase of 20.00% [1] Stocks with Smaller Deviation Rates - Stocks with smaller deviation rates that have just crossed the six-month moving average include: - Garden Holdings (证券代: 300430) with a deviation rate of 13.12% and a price increase of 19.98% [1] - Hongya CNC (证券代: 301033) with a deviation rate of 13.22% and a price increase of 20.00% [1] - Zhongke Sanhuan (证券代: 688314) with a deviation rate of 12.97% and a price increase of 19.99% [1]